The impact of false positive COVID-19 results in an area of low prevalence
Brendan Healy, Azizah Khan, Huria Metezai, Ian Blyth and Hibo Asad
DOI: https://doi.org/10.7861/clinmed.2020-0839
Clin Med January 2021 Brendan Healy
APublic Health Wales Microbiology, Cardiff, UK
Roles: consultant in microbiology and infectious diseases
Azizah Khan
BCardiff University, Cardiff, UK
Roles: year-5 medical student
Huria Metezai
BCardiff University, Cardiff, UK
Roles: year-5 medical student
Ian Blyth
CPublic Health Wales, Swansea, UK and Swansea Bay University Health Board, Swansea, UK
Roles: consultant in microbiology and infectious diseases
Hibo Asad
DPublic Health Wales, Swansea, UK and Swansea Bay University Health Board, Swansea, UK
Roles: healthcare epidemiologist
Article Tools
The impact of false positive COVID-19 results in an area of low prevalence
Brendan Healy, Azizah Khan, Huria Metezai, Ian Blyth, Hibo Asad
Clinical Medicine Jan 2021, 21 (1) e54-e56; DOI: 10.7861/clinmed.2020-0839
Citation Manager Formats
Jump to section
- Article
- ABSTRACT
- Background
- Methods
- Results
- Implications of false positive results
- False positive results in low-prevalence settings
- False positive results in high-prevalence settings
- Challenges of false positive and false negative results
- Causes of false positive results and recommended measures to minimise them
- Conclusion
- Acknowledgements
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- Modulating Cas13a trans-cleavage by double strand RNA: Application to the development of an autocatalytic sensor
- Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial
- Challenges in the case-based surveillance of infectious diseases
- Immunity and infectivity in covid-19
- A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants
- Rapid and Sensitive Detection of SARS-CoV-2 Infection Using Quantitative Peptide Enrichment LC-MS Analysis